haloperidol has been researched along with Cardiovascular Diseases in 10 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone and paliperidone palmitate are two antipsychotic drugs well tolerated in the management of schizophrenia and other psychiatric conditions." | 7.88 | Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability. ( Tagne Nouemssi, AB, 2018) |
| "Risperidone and paliperidone palmitate are two antipsychotic drugs well tolerated in the management of schizophrenia and other psychiatric conditions." | 3.88 | Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability. ( Tagne Nouemssi, AB, 2018) |
| " Generally, the antipsychotics significantly enhanced NRG1/ErbB signaling with increased expression of NRG1 and phosphorylation of ErbB4 and ErbB2 in the brain and myocardium, except that clozapine partly blocked the cardiac NRG1/ErbB2 activation, which could be associated with its more severe cardiac adverse actions." | 1.43 | Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect. ( Cai, H; Dang, R; Guo, Y; Jiang, P; Liang, D; Lv, C; Yang, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DD | 1 |
| Lang, DJ | 1 |
| Procyshyn, RM | 1 |
| Woodward, ML | 1 |
| Kaufman, K | 1 |
| White, RF | 1 |
| Honer, WG | 1 |
| Warburton, DER | 1 |
| Tagne Nouemssi, AB | 1 |
| Dang, R | 1 |
| Guo, Y | 1 |
| Cai, H | 1 |
| Yang, R | 1 |
| Liang, D | 1 |
| Lv, C | 1 |
| Jiang, P | 1 |
| Barak, Y | 1 |
| Swartz, M | 1 |
| Plopsky, I | 1 |
| Ungvári, G | 1 |
| Francis, GS | 1 |
| Barnaulov, OD | 1 |
| Bondarev, RP | 1 |
| Zolotnitskii, RI | 1 |
| Kutsenok, BM | 1 |
| Gastev, MD | 1 |
| Keshavarz-Bahaghighat, H | 1 |
| Darwesh, AM | 1 |
| Sosnowski, DK | 1 |
| Seubert, JM | 1 |
| Moon, MK | 1 |
2 reviews available for haloperidol and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiac complications in the intensive care unit.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cisapride; Electrocardiography; Erythr | 1999 |
Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids.
Topics: Animals; Cardiovascular Diseases; Epoxy Resins; Fatty Acids, Unsaturated; Heart Failure; Humans; Imm | 2020 |
1 trial available for haloperidol and Cardiovascular Diseases
| Article | Year |
|---|---|
Assessing cardiovascular risks of olanzapine treatment: a 6-month study versus haloperidol in schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Female; Haloperidol; Humans; | 2005 |
7 other studies available for haloperidol and Cardiovascular Diseases
| Article | Year |
|---|---|
Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Cardiovascular Diseases; Chronic Disease; Clozapine; Cross-Sectional St | 2018 |
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability.
Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Do | 2018 |
Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.
Topics: Animals; Antipsychotic Agents; Cardiovascular Diseases; Clozapine; Comorbidity; Genetic Predispositi | 2016 |
Neuoleptic-related sudden death (proven or a mere hypothesis?).
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Autopsy; Cardiovascular Diseases; Death, Sudden; Epid | 1980 |
[Use of haloperidol by the emergency team].
Topics: Adult; Affective Symptoms; Aged; Cardiovascular Diseases; Female; First Aid; Haloperidol; Humans; Mi | 1976 |
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall | 1969 |
Concern about the Safety of Bisphenol A Substitutes.
Topics: Benzhydryl Compounds; Biological Monitoring; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Epo | 2019 |